Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet

Bibliographic Details
Main Author: Francisqueti-Ferron, Fabiane Valentini [UNESP]
Publication Date: 2022
Other Authors: Silva, Janaina Paixão das Chagas [UNESP], Garcia, Jéssica Leite [UNESP], Ferron, Artur Junio Togneri [UNESP], Kano, Hugo Tadashi [UNESP], Silva, Carol Cristina Vágula de Almeida [UNESP], Costa, Mariane Róvero [UNESP], Nai, Gisele Alborghetti, Moreto, Fernando [UNESP], Corrêa, Camila Renata [UNESP]
Format: Article
Language: eng
Source: Repositório Institucional da UNESP
Download full: http://dx.doi.org/10.3390/livers2030013
https://hdl.handle.net/11449/303412
Summary: Nonalcoholic fatty liver disease (NAFLD) is the main cause of liver disease. The physiopathological processes involved in the disease are metabolic syndrome (MetS) components (central obesity, dyslipidemia, insulin resistance/type 2 diabetes, hypertension), genetic, and dietary factors, including unsaturated fats and sweetened beverages, which are able to lead to inflammation and oxidative stress, conditions associated with progression and severity of NAFLD. Gamma-oryzanol (γOz) is a nutraceutical obtained from rice brain oil with many benefits to health, from immunological to metabolic. The aim of this study is to test the preventive effect of γOz on the physiopathological process related to nonalcoholic fatty liver disease in animals submitted to high sugar/fat diet. Male Wistar rats (±187 g) were randomly divided into four experimental groups to receive: control diet (C, n = 6), control diet plus γOz (C + γOz, n = 6), high sugar/fat diet (HSF, n = 6), or high sugar/fat diet plus γOz (HSF + γOz, n = 6) during 30 weeks. HSF groups also received water plus sucrose (25%). γOz was added to diets to reach 0.5% of final concentration. The HSF group presented MetS, liver inflammation and oxidative stress, and micro and macrovesicular steatosis. HSF plus γOz was protected against these changes. It is possible to conclude that gamma-oryzanol was effective in modulating the physiopathological process related to nonalcoholic fatty liver disease in animals submitted to a high sugar/fat diet.
id UNSP_07a3b01ff5aaf3ef34cb1ff9b79013cb
oai_identifier_str oai:repositorio.unesp.br:11449/303412
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Dietbioactive compoundsgamma-oryzanolmetabolic syndromenonalcoholic fatty liver diseaseNonalcoholic fatty liver disease (NAFLD) is the main cause of liver disease. The physiopathological processes involved in the disease are metabolic syndrome (MetS) components (central obesity, dyslipidemia, insulin resistance/type 2 diabetes, hypertension), genetic, and dietary factors, including unsaturated fats and sweetened beverages, which are able to lead to inflammation and oxidative stress, conditions associated with progression and severity of NAFLD. Gamma-oryzanol (γOz) is a nutraceutical obtained from rice brain oil with many benefits to health, from immunological to metabolic. The aim of this study is to test the preventive effect of γOz on the physiopathological process related to nonalcoholic fatty liver disease in animals submitted to high sugar/fat diet. Male Wistar rats (±187 g) were randomly divided into four experimental groups to receive: control diet (C, n = 6), control diet plus γOz (C + γOz, n = 6), high sugar/fat diet (HSF, n = 6), or high sugar/fat diet plus γOz (HSF + γOz, n = 6) during 30 weeks. HSF groups also received water plus sucrose (25%). γOz was added to diets to reach 0.5% of final concentration. The HSF group presented MetS, liver inflammation and oxidative stress, and micro and macrovesicular steatosis. HSF plus γOz was protected against these changes. It is possible to conclude that gamma-oryzanol was effective in modulating the physiopathological process related to nonalcoholic fatty liver disease in animals submitted to a high sugar/fat diet.Medical School São Paulo State University (UNESP), SPInstitute of Biosciences São Paulo State University (UNESP), SPDepartment of Pathological Anatomy and Cytopathology Universidade do Oeste Paulista (UNOESTE), SPMedical School São Paulo State University (UNESP), SPInstitute of Biosciences São Paulo State University (UNESP), SPUniversidade Estadual Paulista (UNESP)Universidade do Oeste Paulista (UNOESTE)Francisqueti-Ferron, Fabiane Valentini [UNESP]Silva, Janaina Paixão das Chagas [UNESP]Garcia, Jéssica Leite [UNESP]Ferron, Artur Junio Togneri [UNESP]Kano, Hugo Tadashi [UNESP]Silva, Carol Cristina Vágula de Almeida [UNESP]Costa, Mariane Róvero [UNESP]Nai, Gisele AlborghettiMoreto, Fernando [UNESP]Corrêa, Camila Renata [UNESP]2025-04-29T19:29:31Z2022-09-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article146-157http://dx.doi.org/10.3390/livers2030013Livers, v. 2, n. 3, p. 146-157, 2022.2673-4389https://hdl.handle.net/11449/30341210.3390/livers20300132-s2.0-85145849773Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengLiversinfo:eu-repo/semantics/openAccess2025-04-30T14:08:57Zoai:repositorio.unesp.br:11449/303412Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462025-04-30T14:08:57Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet
title Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet
spellingShingle Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet
Francisqueti-Ferron, Fabiane Valentini [UNESP]
bioactive compounds
gamma-oryzanol
metabolic syndrome
nonalcoholic fatty liver disease
title_short Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet
title_full Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet
title_fullStr Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet
title_full_unstemmed Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet
title_sort Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet
author Francisqueti-Ferron, Fabiane Valentini [UNESP]
author_facet Francisqueti-Ferron, Fabiane Valentini [UNESP]
Silva, Janaina Paixão das Chagas [UNESP]
Garcia, Jéssica Leite [UNESP]
Ferron, Artur Junio Togneri [UNESP]
Kano, Hugo Tadashi [UNESP]
Silva, Carol Cristina Vágula de Almeida [UNESP]
Costa, Mariane Róvero [UNESP]
Nai, Gisele Alborghetti
Moreto, Fernando [UNESP]
Corrêa, Camila Renata [UNESP]
author_role author
author2 Silva, Janaina Paixão das Chagas [UNESP]
Garcia, Jéssica Leite [UNESP]
Ferron, Artur Junio Togneri [UNESP]
Kano, Hugo Tadashi [UNESP]
Silva, Carol Cristina Vágula de Almeida [UNESP]
Costa, Mariane Róvero [UNESP]
Nai, Gisele Alborghetti
Moreto, Fernando [UNESP]
Corrêa, Camila Renata [UNESP]
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (UNESP)
Universidade do Oeste Paulista (UNOESTE)
dc.contributor.author.fl_str_mv Francisqueti-Ferron, Fabiane Valentini [UNESP]
Silva, Janaina Paixão das Chagas [UNESP]
Garcia, Jéssica Leite [UNESP]
Ferron, Artur Junio Togneri [UNESP]
Kano, Hugo Tadashi [UNESP]
Silva, Carol Cristina Vágula de Almeida [UNESP]
Costa, Mariane Róvero [UNESP]
Nai, Gisele Alborghetti
Moreto, Fernando [UNESP]
Corrêa, Camila Renata [UNESP]
dc.subject.por.fl_str_mv bioactive compounds
gamma-oryzanol
metabolic syndrome
nonalcoholic fatty liver disease
topic bioactive compounds
gamma-oryzanol
metabolic syndrome
nonalcoholic fatty liver disease
description Nonalcoholic fatty liver disease (NAFLD) is the main cause of liver disease. The physiopathological processes involved in the disease are metabolic syndrome (MetS) components (central obesity, dyslipidemia, insulin resistance/type 2 diabetes, hypertension), genetic, and dietary factors, including unsaturated fats and sweetened beverages, which are able to lead to inflammation and oxidative stress, conditions associated with progression and severity of NAFLD. Gamma-oryzanol (γOz) is a nutraceutical obtained from rice brain oil with many benefits to health, from immunological to metabolic. The aim of this study is to test the preventive effect of γOz on the physiopathological process related to nonalcoholic fatty liver disease in animals submitted to high sugar/fat diet. Male Wistar rats (±187 g) were randomly divided into four experimental groups to receive: control diet (C, n = 6), control diet plus γOz (C + γOz, n = 6), high sugar/fat diet (HSF, n = 6), or high sugar/fat diet plus γOz (HSF + γOz, n = 6) during 30 weeks. HSF groups also received water plus sucrose (25%). γOz was added to diets to reach 0.5% of final concentration. The HSF group presented MetS, liver inflammation and oxidative stress, and micro and macrovesicular steatosis. HSF plus γOz was protected against these changes. It is possible to conclude that gamma-oryzanol was effective in modulating the physiopathological process related to nonalcoholic fatty liver disease in animals submitted to a high sugar/fat diet.
publishDate 2022
dc.date.none.fl_str_mv 2022-09-01
2025-04-29T19:29:31Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.3390/livers2030013
Livers, v. 2, n. 3, p. 146-157, 2022.
2673-4389
https://hdl.handle.net/11449/303412
10.3390/livers2030013
2-s2.0-85145849773
url http://dx.doi.org/10.3390/livers2030013
https://hdl.handle.net/11449/303412
identifier_str_mv Livers, v. 2, n. 3, p. 146-157, 2022.
2673-4389
10.3390/livers2030013
2-s2.0-85145849773
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Livers
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 146-157
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv repositoriounesp@unesp.br
_version_ 1834482417988009984